Roland E. Schmieder researcher
Schmieder, Roland E.
Schmieder, R.
Schmieder, R. E. (Roland E.)
VIAF ID: 20148207864800342071 (Personal)
Permalink: http://viaf.org/viaf/20148207864800342071
Preferred Forms
- 100 0 _ ‡a Roland E. Schmieder ‡c researcher
- 100 1 _ ‡a Schmieder, R.
-
- 100 1 _ ‡a Schmieder, R. E. ‡q (Roland E.)
- 100 1 _ ‡a Schmieder, Roland E.
- 100 1 _ ‡a Schmieder, Roland E.
- 100 1 _ ‡a Schmieder, Roland E.
4xx's: Alternate Name Forms (2)
5xx's: Related Names (1)
Works
Title | Sources |
---|---|
Achievement of individualized treatment targets in patients with comorbid type-2 diabetes and hypertension: 6 months results of the DIALOGUE registry | |
Baseline Characteristics and Prescription Patterns of Standard Drugs in Patients with Angiographically Determined Coronary Artery Disease and Renal Failure (CAD-REF Registry) | |
Bluthochdruck - mein Lernbuch was Sie zum Bluthochdruck und seinen Folgen wissen sollten uns was Sie selbst zur Blutdrucksenkung tun können | |
[BP.08.01] EVALUATION OF RETINAL MICROPERFUSION AND ARTERIOLAR STRUCTURE IN PATIENTS WITH FIBROMUSCULAR DYSPLASIA – THE POLISH REGISTRY FOR FIBROMUSCULAR DYSPLASIA (ARCADIA-POL STUDY) | |
[Diagnosis, implication, prevention and treatment of microalbuminuria] | |
Disparate cardiovascular findings in men and women with essential hypertension | |
Disparate cardiovascular response to stress tests during isradipine and fosinopril therapy | |
Disparate hemodynamic and sympathoadrenergic responses to isometric and mental stress in essential hypertension. | |
Disparate hemodynamic responses to mental challenge after antihypertensive therapy with beta blockers and calcium entry blockers | |
Disparities in blood pressure control under various antihypertensive regimens | |
Disproportional decrease in office blood pressure compared with 24-hour ambulatory blood pressure with antihypertensive treatment: dependency on pretreatment blood pressure levels. | |
Diuretic therapy and the risk for renal cell carcinoma | |
Does renal artery supply indicate treatment success of renal denervation? | |
Does the renin-angiotensin-aldosterone system modify cardiac structure and function in essential hypertension? | |
Dual RAAS suppression: recent developments and implications in light of the ALTITUDE study | |
Early detection of target organ disease in essential hypertension. | |
Early Signs of End-Organ Damage in Retinal Arterioles in Patients with Type 2 Diabetes Compared to Hypertensive Patients | |
EARLY Treatment with azilsartan compared to ACE-inhibitors in anti-hypertensive therapy--rationale and design of the EARLY hypertension registry | |
Early vascular parameters in the micro- and macrocirculation in type 2 diabetes | |
Effect of aliskiren on vascular remodelling in small retinal circulation | |
Effect of Arteriovenous Anastomosis on Blood Pressure Reduction in Patients With Isolated Systolic Hypertension Compared With Combined Hypertension. | |
Effect of erythropoietin on cardiovascular prognosis parameters in hemodialysis patients. | |
Effect of irbesartan versus atenolol on left ventricular mass and voltage: results of the CardioVascular Irbesartan Project | |
Effect of renal denervation in attenuating the stress of morning surge in blood pressure: post-hoc analysis from the SPYRAL HTN-ON MED trial | |
Effect of rosuvastatin on outcomes in chronic haemodialysis patients: baseline data from the AURORA study | |
Effect of telmisartan on renal outcomes: a randomized trial. | |
Effectiveness and tolerability of a fixed-dose combination of olmesartan and amlodipine in clinical practice. | |
Effects of angiotensin converting enzyme inhibitor on renal haemodynamics during mental stress. | |
Effects of beta-blockers on type-A coronary-prone behaviour | |
Effects of bromocriptine on cardiovascular regulation in healthy humans. | |
Effects of continuous haemofiltration vs intermittent haemodialysis on systemic haemodynamics and splanchnic regional perfusion in septic shock patients: a prospective, randomized clinical trial | |
Effects of enalapril and eprosartan on the renal vascular nitric oxide system in human essential hypertension | |
Effects of linagliptin on renal endothelial function in patients with type 2 diabetes: a randomised clinical trial | |
[Effects of long-term antihypertensive therapy with losartan on blood pressure and cognitive function in patients with essential hypertension and other cerebrovascular risk factors | |
Effects of manidipine vs. amlodipine on intrarenal haemodynamics in patients with arterial hypertension | |
Effects of naloxone on hemodynamic and sympathetic nerve responses to pain in normotensive vs. borderline hypertensive men | |
Effects of nitric oxide synthase inhibition and L-arginine on renal haemodynamics in young patients at high cardiovascular risk | |
Effects of nonpersistence with medication on outcomes in high-risk patients with cardiovascular disease | |
Effects of oral contraceptives on vascular endothelium in premenopausal women | |
Effects of renal denervation on kidney function and long-term outcomes: 3-year follow-up from the Global SYMPLICITY Registry | |
Effects of renal sympathetic denervation on urinary sodium excretion in patients with resistant hypertension. | |
Effects of statin treatment on endothelial function, oxidative stress and inflammation in patients with arterial hypertension and normal cholesterol levels. | |
Effects of sympathetic nerves and angiotensin II on renal sodium and water handling in rats with common bile duct ligature | |
Einflussmöglichkeiten auf die Progression einer Herz- und Niereninsuffizienz : Wunschvorstellung oder Realität? | |
Endorganschädigungen der arteriellen Hypertonie, c1991: | |
Guía de práctica clínica de la ESH/ESC para el manejo de la hipertensión arterial | |
How does empagliflozin improve arterial stiffness in patients with type 2 diabetes mellitus? Sub analysis of a clinical trial | |
Interventional Therapies for Secondary and Essential Hypertension | |
[A model project on shared decision-making in the treatment of arterial hypertension] | |
Obesity as a determinant for response to antihypertensive treatment | |
Olmesartan improves pulse wave velocity and lowers central systolic blood pressure and ambulatory blood pressure in patients with metabolic syndrome | |
Update on reversal of left ventricular hypertrophy in essential hypertension (a meta-analysis of all randomized double-blind studies until December 1996). | |
Urinary albumin excretion from spot urine samples predict all-cause and stroke mortality in Africans | |
Urinary collagen fragments are significantly altered in diabetes: a link to pathophysiology | |
Urinary proteomic diagnosis of coronary artery disease: identification and clinical validation in 623 individuals | |
Urinary sodium and potassium excretion and risk of cardiovascular events | |
Use of diuretic agents in obese or black patients with systemic hypertension | |
Validation of a therapeutic scheme for the treatment of resistant hypertension | |
Vascular and renal hemodynamic changes after renal denervation | |
Vascular reactivity in patients with preeclampsia and HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome | |
[Ventricular arrhythmia and sudden cardiac death: the significance of left ventricular hypertrophy as risk factor] | |
Visit-to-visit blood pressure variability and renal outcomes: results from ONTARGET and TRANSCEND trials | |
Vitamin C augments the renal response to L-arginine in smokers | |
Wall-to-lumen ratio of retinal arterioles: a reproducible, valid and noninvasive approach for evaluation of early arteriolar changes in arterial hypertension in vivo | |
Wall-to-lumen ratio of retinal arterioles is related with urinary albumin excretion and altered vascular reactivity to infusion of the nitric oxide synthase inhibitor N-monomethyl-L-arginine | |
What the interventionalist should know about renal denervation in hypertensive patients: a position paper by the ESH WG on the interventional treatment of hypertension | |
When is discontinuation of antihypertensive therapy indicated? | |
Why in 2016 are patients with hypertension not 100% controlled? A call to action | |
Wilder's principle: pre-treatment value determines post-treatment response | |
Will SPRINT change my practice? SPRINT: a randomised trial of intensive versus standard blood-pressure control | |
প্রত্যুত্তর |